(firstQuint)A Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand.

 Subjects will be randomized into one of three groups.

 One group will receive a placebo vaccine and the other two will receive different dengue vaccine formations.

 Each subject will receive two doses six months apart.

 All subjects will have 11 venipunctures during 11 visits (i.

e.

, screening plus 10 study visits) over a period of nine months.

.

 A Phase II Trial of a Live Attenuated Virus Tetravalent Dengue Vaccine in Healthy Adults in Thailand@highlight

This descriptive study will evaluate the safety and immunogenicity of different formulations of the WRAIR dengue vaccine compared to a placebo.

